Dose painting by numbers in a standard treatment planning system using inverted dose prescription maps

被引:22
作者
Arnesen, Marius Rothe [1 ,2 ]
Knudtsen, Ingerid Skjei [1 ,2 ]
Rekstad, Bernt Louni [1 ]
Eilertsen, Karsten [1 ]
Dale, Einar [3 ]
Bruheim, Kjersti [3 ]
Helland, Aslaug [3 ]
Londalen, Ayca Muftuler [4 ]
Hellebust, Taran Paulsen [1 ,2 ]
Malinen, Eirik [1 ,2 ]
机构
[1] Oslo Univ Hosp, Norwegian Radium Hosp, Dept Med Phys, N-0424 Oslo, Norway
[2] Univ Oslo, Dept Phys, Oslo, Norway
[3] Oslo Univ Hosp, Dept Oncol, N-0424 Oslo, Norway
[4] Oslo Univ Hosp, Dept Radiol & Nucl Med, N-0424 Oslo, Norway
关键词
CELL LUNG-CANCER; POSITRON-EMISSION-TOMOGRAPHY; NECK-CANCER; RADIATION-THERAPY; GEOMETRIC UNCERTAINTIES; PROGNOSTIC VALUE; BASE-LINE; HEAD; RADIOTHERAPY; OPTIMIZATION;
D O I
10.3109/0284186X.2015.1061690
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background. Dose painting by numbers (DPBN) is a method to deliver an inhomogeneous tumor dose voxel-by-voxel with a prescription based on biological medical images. However, planning of DPBN is not supported by commercial treatment planning systems (TPS) today. Here, a straightforward method for DPBN with a standard TPS is presented.Material and methods. DPBN tumor dose prescription maps were generated from F-18-FDG-PET images applying a linear relationship between image voxel value and dose. An inverted DPBN prescription map was created and imported into a standard TPS where it was defined as a mock pre-treated dose. Using inverse optimization for the summed dose, a planned DPBN dose distribution was created. The procedure was tested in standard TPS for three different tumor cases; cervix, lung and head and neck. The treatment plans were compared to the prescribed DPBN dose distribution by three-dimensional (3D) gamma analysis and quality factors (QFs). Delivery of the DPBN plans was assessed with portal dosimetry (PD).Results. Maximum tumor doses of 149%, 140% and 151% relative to the minimum tumor dose were prescribed for the cervix, lung and head and neck case, respectively. DPBN distributions were well achieved within the tumor whilst normal tissue doses were within constraints. Generally, high gamma pass rates (> 89% at 2%/2 mm) and low QFs (< 2.6%) were found. PD showed that all DPBN plans could be successfully delivered.Conclusions. The presented methodology enables the use of currently available TPSs for DPBN planning and delivery and may therefore pave the way for clinical implementation.
引用
收藏
页码:1607 / 1613
页数:7
相关论文
共 27 条
  • [1] Identification of residual metabolic-active areas within individual NSCLC tumours using a pre-radiotherapy 18Fluorodeoxyglucose-PET-CT scan
    Aerts, Hugo J. W. L.
    van Baardwijk, Angela A. W.
    Petit, Steven F.
    Offermann, Claudia
    van Loon, Judith
    Houben, Ruud
    Dingemans, Anne-Marie C.
    Wanders, Rinus
    Boersma, Liesbeth
    Borger, Jacques
    Bootsma, Gerben
    Geraedts, Wiel
    Pitz, Cordula
    Simons, Jean
    Wouters, Bradly G.
    Oellers, Michel
    Lambin, Philippe
    Bosmans, Geert
    Dekker, Andre L. A. J.
    De Ruysscher, Dirk
    [J]. RADIOTHERAPY AND ONCOLOGY, 2009, 91 (03) : 386 - 392
  • [2] On biologically conformal boost dose optimization
    Alber, M
    Paulsen, F
    Eschmann, SM
    Machulla, HJ
    [J]. PHYSICS IN MEDICINE AND BIOLOGY, 2003, 48 (02) : N31 - N35
  • [3] Prediction of outcome in head-and-neck cancer patients using the standardized uptake value of 2-[18F]fluoro-2-deoxy-D-glucose
    Allal, AS
    Slosman, DO
    Kebdani, T
    Allaoua, M
    Lehmann, W
    Dulguerov, P
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2004, 59 (05): : 1295 - 1300
  • [4] Theragnostic imaging for radiation oncology: dose-painting by numbers
    Bentzen, SM
    [J]. LANCET ONCOLOGY, 2005, 6 (02) : 112 - 117
  • [5] Molecular Imaging-Based Dose Painting: A Novel Paradigm for Radiation Therapy Prescription
    Bentzen, Soren M.
    Gregoire, Vincent
    [J]. SEMINARS IN RADIATION ONCOLOGY, 2011, 21 (02) : 101 - 110
  • [6] Three-phase adaptive dose-painting-by-numbers for head-and-neck cancer: initial results of the phase I clinical trial
    Berwouts, Dieter
    Olteanu, Luiza A. M.
    Duprez, Frederic
    Vercauteren, Tom
    De Gersem, Werner
    De Neve, Wilfried
    Van de Wiele, Christophe
    Madani, Indira
    [J]. RADIOTHERAPY AND ONCOLOGY, 2013, 107 (03) : 310 - 316
  • [7] Standardised FDG uptake: A prognostic factor for inoperable non-small cell lung cancer
    Borst, GR
    Belderbos, JSA
    Boellaard, R
    Comans, EFI
    De Jaeger, K
    Lammertsma, AA
    Lebesque, JV
    [J]. EUROPEAN JOURNAL OF CANCER, 2005, 41 (11) : 1533 - 1541
  • [8] Prognostic value of metabolic metrics extracted from baseline positron emission tomography images in non-small cell lung cancer
    Carvalho, Sara
    Leijenaar, Ralph T. H.
    Velazquez, Emmanuel Rios
    Oberije, Cary
    Parmar, Chintan
    Van Elmpt, Wouter
    Reymen, Bart
    Troost, Esther G. C.
    Oellers, Michel
    Dekker, Andre
    Gillies, Robert
    Aerts, Hugo J. W. L.
    Lambin, Philippe
    [J]. ACTA ONCOLOGICA, 2013, 52 (07) : 1398 - 1404
  • [9] Feasibility and sensitivity study of helical tomotherapy for dose painting plans
    Deveau, Michael A.
    Bowen, Stephen R.
    Westerly, David C.
    Jeraj, Robert
    [J]. ACTA ONCOLOGICA, 2010, 49 (07) : 991 - 996
  • [10] Recurrences after intensity modulated radiotherapy for head and neck squamous cell carcinoma more likely to originate from regions with high baseline [18F]-FDG uptake
    Due, Anne K.
    Vogelius, Ivan R.
    Aznar, Marianne C.
    Bentzen, Soren M.
    Berthelsen, Anne K.
    Korreman, Stine S.
    Loft, Annika
    Kristensen, Claus A.
    Specht, Lena
    [J]. RADIOTHERAPY AND ONCOLOGY, 2014, 111 (03) : 360 - 365